| 000 | 01665 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514032031.0 | ||
| 264 | 0 | _c20020916 | |
| 008 | 200209s 0 0 eng d | ||
| 022 | _a0141-9854 | ||
| 024 | 7 |
_a10.1046/j.1365-2257.2002.00437.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndrès, E | |
| 245 | 0 | 0 |
_aNonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature. _h[electronic resource] |
| 260 |
_bClinical and laboratory haematology _cApr 2002 |
||
| 300 |
_a99-106 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntithyroid Agents _xadverse effects |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aInfections _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aKurtz, J-E | |
| 700 | 1 | _aMaloisel, F | |
| 773 | 0 |
_tClinical and laboratory haematology _gvol. 24 _gno. 2 _gp. 99-106 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2257.2002.00437.x _zAvailable from publisher's website |
| 999 |
_c11885555 _d11885555 |
||